Protein kinase inhibitors as therapeutics in neurodegenerative and psychiatric disorders: progress, challenges, and recommendations

Pharmacology, Toxicology and Pharmaceutical Science

• Protein Kinase Inhibitor 100%
• Masitinib 100%
• Nilotinib 50%
• Rapamycin 50%
• Monepantel 50%
• Trametinib 50%
• Saracatinib 50%
• Evobrutinib 50%
• Neflamapimod 50%
• Fenebrutinib 50%
• Antisense Oligonucleotide 50%
• Fasudil 50%
• Nusinersen 50%
• Baricitinib 50%
• Tofersen 50%
• Dasatinib 50%
• Bosutinib 50%
• Tofacitinib 50%
• Tideglusib 50%